Lynne M. Powell

2017

In 2017, Lynne M. Powell earned a total compensation of $1.5M as Senior Vice President and Chief Commercial Officer at BioCryst Pharmaceuticals, a 121% increase compared to previous year.

Compensation breakdown

Bonus$122,570
Non-Equity Incentive Plan$111,395
Option Awards$838,543
Salary$369,513
Other$45,066
Total$1,487,087

Powell received $838.5K in option awards, accounting for 56% of the total pay in 2017.

Powell also received $122.6K in bonus, $111.4K in non-equity incentive plan, $369.5K in salary and $45.1K in other compensation.

Rankings

In 2017, Lynne M. Powell's compensation ranked 7,027th out of 14,666 executives tracked by ExecPay. In other words, Powell earned more than 52.1% of executives.

ClassificationRankingPercentile
All
7,027
out of 14,666
52nd
Division
Manufacturing
2,609
out of 5,772
55th
Major group
Chemicals And Allied Products
847
out of 2,075
59th
Industry group
Drugs
660
out of 1,731
62nd
Industry
Biological Products, Except Diagnostic Substances
123
out of 313
61st
Source: SEC filing on May 10, 2018.

Powell's colleagues

We found four more compensation records of executives who worked with Lynne M. Powell at BioCryst Pharmaceuticals in 2017.

2017

Jon Stonehouse

BioCryst Pharmaceuticals

Chief Executive Officer

2017

William Sheridan

BioCryst Pharmaceuticals

Chief Medical Officer

2017

Thomas Staab

BioCryst Pharmaceuticals

Chief Financial Officer

2017

Yarlagadda Babu

BioCryst Pharmaceuticals

Senior Vice President of Drug Discovery

News

In-depth

You may also like